A Phase II Study of PEG-rhGH Injection for Short Children Born Small for Gestational Age: Efficacy, Safety, and Pharmacokinetics

Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2025
This study will take place at multiple sites and is divided into three phases:an initial 4-week getting-to-know-you phase,a 26-week main phase where participants receive medication,and a 4-week follow-up phase.Participants will be divided into three groups:two will receive different doses of PEG-rhGH Injection,and the third will receive hGH Injection.The goal is to determine which medication works best.
Epistemonikos ID: 7e33c6bcd5b6ff992617c24ded6a79d0d54e6082
First added on: Dec 04, 2025